Literature DB >> 12531347

Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.

H E de Melker1, S van den Hof, G A M Berbers, M A E Conyn-van Spaendonck.   

Abstract

The immunity to vaccine-preventable diseases included in the Dutch immunisation programme in the general population and among orthodox reformed individuals who refuse vaccination was assessed. The programme induces good protection. However, a large proportion of adults lacks diphtheria and tetanus immunity. Measles, mumps and rubella seroprevalence was somewhat lower among vaccinated compared to unvaccinated cohorts. The prevalence of HibPS antibodies declined during 2.5 years after the fourth vaccination. However, protection occurs also by memory immunity. Herd immunity is sufficient among the general population, but not among orthodox reformed individuals. Immunosurveillance is an efficient way to evaluate the effects of immunisation programmes and identify risk groups for infection.

Entities:  

Mesh:

Year:  2003        PMID: 12531347     DOI: 10.1016/s0264-410x(02)00587-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  The seroepidemiology of tetanus in Catalonia, Spain.

Authors:  A Domínguez; P Plans; J Costa; J Espuñes; N Cardeñosa; L Salleras; A Plasència
Journal:  Med Microbiol Immunol       Date:  2007-01-23       Impact factor: 3.402

2.  Immune Dysfunction in Children with CHARGE Syndrome: A Cross-Sectional Study.

Authors:  Monica T Y Wong; Annechien J A Lambeck; Mirjam van der Burg; Sacha la Bastide-van Gemert; Lianne A Hogendorf; Conny M A van Ravenswaaij-Arts; Elisabeth H Schölvinck
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

3.  Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.

Authors:  Joske Hoes; Anna G C Boef; Mirjam J Knol; Hester E de Melker; Liesbeth Mollema; Fiona R M van der Klis; Nynke Y Rots; Debbie van Baarle
Journal:  Front Public Health       Date:  2018-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.